Authors

Cancer-Killing Virus Looks Promising

In March, the television news show 60 Minutes devoted a segment to a clinical trial using polio virus to treat glioblastoma multiforme. The segment called "Killing Cancer" did a good job of illustrating the potential power of this new treatment as well as the problems associated with glioblastoma multiforme which typically kills patients in a matter of months.

Cruise the River of Kings in Bangkok

Face the Facts and Find Investor Peace

MUSC Pilot Program Shows Success in Treating Opioid Users

Research demonstrates that medication-assisted treatment for opioid addiction works, yet few have adopted it.

Are statins cardioprotective in patients undergoing major vascular surgery?

We evaluated the cardioprotective effects of intensive statin therapy before major vascular surgery in a prospective study of 359 subjects. After multivariate analysis, lower low-density lipoprotein (LDL) cholesterol was associated with decreased myocardial ischemia, troponin T release, and 30-day and late cardiac events. Furthermore, higher doses of statins were associated with better cardiac outcome, even after adjusting for LDL cholesterol.

Radiofrequency ablation vs medical therapy after a first episode of symptomatic atrial flutter

Atrial flutter is an arrhythmia that occurs less commonly than atrial fibrillation and is often resistant to rate control and termination.

Maximize Your Digital Front Door During COVID-19

A look at the available and viable tools to continue patient access and care.

Take An Expert Approach to Retirement

Lipoprotein(a) and coronary artery disease:

The well-established causative role of low-density lipoprotein particles in atherosclerotic plaque development has led to this biomarker being a primary target of treatment in the prevention of coronary artery disease.

Roshni Patel, BSc, MCOptom: The State of Glaucoma in 2020

An optometrist from Europe discusses the current state of glaucoma from identification to treatment.

NDA for NTM Lung Disease Treatment Submitted to FDA

Insmed Incorporated announced that it has submitted its New Drug Application for amikacin liposome inhalation suspension (ALIS) to the U.S. FDA.

Patent foramen ovale closure for stroke prevention: A myriad of unanswered questions

Migraines, including those with aura, are common and generally benign, affecting between 10% and 15% of the population.

Avoid Costly IRA Planning Mistakes